What is the ROE (Return on Equity) of Penumbra this year?
The ROE of Penumbra this year is 0.08 undefined.
Penumbra ROE 2024
Penumbra ROE
0.08
Ticker
PEN
ISIN
US70975L1070
WKN
A14Y65
In 2024, Penumbra's return on equity (ROE) was 0.08, a -3,953.19% increase from the -0 ROE in the previous year.
Penumbra Aktienanalyse
What does Penumbra do?
Penumbra Inc is an American company specializing in medical technology. It was founded in 2004 and is headquartered in Alameda, California. The company has branches and subsidiaries worldwide. It offers various products for the treatment of strokes, aneurysms, vascular injuries, and other medical conditions. The history of Penumbra Inc began with the founder and CEO Adam Elsesser's vision to develop innovative technologies to help patients with challenging medical conditions. The company started with just one product, the Penumbra 3D Coiling Technology, which is used for the treatment of brain aneurysms. Penumbra Inc's business model is based on the development and marketing of innovative medical devices and technologies to assist surgeons and specialists in treating their patients better. The company conducts intensive research and development to create new products that meet market demand. Penumbra Inc is divided into different divisions to offer a comprehensive range of medical tools and devices to its customers. The main divisions of the company are Neuro, Vascular, and Oncology. Under the Neuro division, Penumbra Inc offers a wide range of devices and technologies for the treatment of strokes and trauma. This includes the Penumbra Coil 400, used for treating intracranial aneurysms, and the Penumbra Jet 7 Reperfusion Catheter, an innovative technology for restoring blood flow in stroke patients' brains. The Vascular division of Penumbra Inc provides devices for the treatment of vascular diseases, such as endovascular repairs of aortic aneurysms. This division utilizes the innovative Penumbra SMART Coil technology, which provides improved handling and safety. The Oncology division of Penumbra Inc focuses on developing technologies to enhance healthcare for cancer patients. This includes innovative drug delivery devices, such as the Penumbra System used in brachytherapy. Penumbra Inc is a leading provider of medical devices and technologies used in the treatment of complex medical conditions. Over the past decade, the company has established its reputation in the industry. Continuous investment in research and development and a focus on patient and medical professionals' needs have solidified Penumbra Inc's success in the international market. Penumbra ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROE Details
Decoding Penumbra's Return on Equity (ROE)
Penumbra's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.
Year-to-Year Comparison
Analyzing Penumbra's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.
Impact on Investments
Penumbra's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.
Interpreting ROE Fluctuations
Changes in Penumbra’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.
Frequently Asked Questions about Penumbra stock
How has the Return on Equity (ROE) of Penumbra developed compared to the previous year?
The ROE of Penumbra has increased by -3,953.19% decreased compared to the previous year.
What impact does a high ROE (Return on Equity) have on investors of Penumbra?
A high ROE indicates that Penumbra generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.
What impact does a low ROE (Return on Equity) have on investors of Penumbra?
A low ROE can indicate that Penumbra is having difficulties monetizing its investments successfully and can be a negative signal for investors.
How does a change in the ROE (Return on Equity) of Penumbra affect the company?
A change in ROE (Return on Equity) of Penumbra can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.
How to calculate the ROE (Return on Equity) of Penumbra?
The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.
Which factors influence the ROE (Return on Equity) of Penumbra?
Some factors that can influence Penumbra's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.
What strategic measures can take to improve the ROE (Return on Equity)?
To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.
How much dividend does Penumbra pay?
Over the past 12 months, Penumbra paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Penumbra is expected to pay a dividend of 0 USD.
What is the dividend yield of Penumbra?
The current dividend yield of Penumbra is .
When does Penumbra pay dividends?
Penumbra pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Penumbra?
Penumbra paid dividends every year for the past 0 years.
What is the dividend of Penumbra?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Penumbra located?
Penumbra is assigned to the 'Health' sector.
Wann musste ich die Aktien von Penumbra kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Penumbra from 9/29/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/29/2024.
When did Penumbra pay the last dividend?
The last dividend was paid out on 9/29/2024.
What was the dividend of Penumbra in the year 2023?
In the year 2023, Penumbra distributed 0 USD as dividends.
In which currency does Penumbra pay out the dividend?
The dividends of Penumbra are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Penumbra stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Penumbra
Our stock analysis for Penumbra Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Penumbra Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
